Bongers BJ, IJzerman AP, Van Westen GJP. Proteochemometrics - recent developments in bioactivity and selectivity modeling.
DRUG DISCOVERY TODAY. TECHNOLOGIES 2019;
32-33:89-98. [PMID:
33386099 DOI:
10.1016/j.ddtec.2020.08.003]
[Citation(s) in RCA: 18] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/28/2020] [Revised: 08/18/2020] [Accepted: 08/28/2020] [Indexed: 06/12/2023]
Abstract
Proteochemometrics is a machine learning based modeling approach relying on a combination of ligand and protein descriptors. With ongoing developments in machine learning and increases in public data the technique is more frequently applied in early drug discovery, typically in ligand-target binding prediction. Common applications include improvements to single target quantitative structure-activity relationship models, protein selectivity and promiscuity modeling, and large-scale deep learning approaches. The increase in predictive power using proteochemometrics is observed in multi-target bioactivity modeling, opening the door to more extensive studies covering whole protein families. On top of that, with deep learning fueling more complex and larger scale models, proteochemometrics allows faster and higher quality computational models supporting the design, make, test cycle.
Collapse